# Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency

> **NCT02456688** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Imrecoxib

## Key facts

- **NCT ID:** NCT02456688
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02456688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02456688, "Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT02456688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*